Chronic obstructive pulmonary disease (COPD) is a large and growing burden on society. Since 1990, the mortality rate from COPD has increased by 58% in the USA, making COPD the second leading cause of mortality in the country. 1 Superficially, these alarming data seem paradoxical in the face of falling smoking prevalence in high-income countries and the substantial progress in the pharmacological management of COPD. Whereas 20 years ago the most common drugs for COPD were short-acting bronchodilat ...
Sté Tunisienne des Maladies Respiratoires et d'Allergologie
Cercle des Bureaux - Appartement B 5-3 . 1082 Centre urbain Nord Tunis
